We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Abuja Heart Study: Prospective Epidemiological Investigation of Cardiovascular Diseases (AHS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00629954
Recruitment Status : Unknown
Verified August 2012 by uchenna onyeachom, Healthsystem Plus.
Recruitment status was:  Recruiting
First Posted : March 6, 2008
Last Update Posted : September 26, 2013
Sponsor:
Collaborators:
Federal Ministry of Health, Nigeria
Akaza Research
Byrne Healthcare
Baim Institute for Clinical Research
Information provided by (Responsible Party):
uchenna onyeachom, Healthsystem Plus

Brief Summary:
This is a multi-site prospective epidemiological investigation of cardiovascular disease (CVD) among Abuja residents from the rural and metropolitan area.

Condition or disease
Cardiovascular Diseases High Blood Pressure

Detailed Description:

Sub-Saharan Africa continues to fight the battle of infectious diseases such as HIV/AIDS, Tuberculosis and Malaria. But given all the international efforts geared to curing and containing these diseases, and with progress made in various countries, Sub-Saharan Africa is now heading into another type of epidemic, cardiovascular disease (CVD). Predicted statistics have shown that cardiovascular diseases will become the leading cause of death in developing countries within the next 10 to 15 years, however relatively few population-based studies have examined CVD in Africa .

Although control of communicable ,childhood ,and maternal diseases has benefited from an international efforts on clinical care, policy and implementation,such large scale effort are lacking for CVD and have left both policymakers and individuals with decisions on health issues without adequate information.

Prior to the commencement of the study,series of community meetings and focus groups discussions will be held to identify ways to enhance participation. An extensive examination will include a series of questionnaires dealing with lifestyle habits, medical history, social and cultural factors, physical assessments which include height, weight,central blood pressure assessment of arterial stiffness and autonomic function and laboratory measurements for cholesterol, other lipids, glucose ,c-reactive protein among others.


Study Type : Observational
Estimated Enrollment : 10000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Abuja Heart Study (AHS) is a Multi-site Prospective Epidemiological Investigation of Cardiovascular Disease (CVD) .
Study Start Date : November 2009
Estimated Primary Completion Date : November 2014
Estimated Study Completion Date : November 2016

Group/Cohort
I



Primary Outcome Measures :
  1. determine the roles of sociocultural factors, such as poverty,gender, literacy, stress in the development of CVD and associated risk factors [ Time Frame: 5 ]

Secondary Outcome Measures :
  1. familial or hereditary factors [ Time Frame: 10 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Abuja residents from the rural and metropolitan area.
Criteria

Inclusion Criteria:

  • Some history of cardiovascular disease,PLWHA
  • Patients have to agree to participate by signing a consent
  • 18 years and older

Exclusion Criteria:

  • Stroke

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00629954


Contacts
Contact: Uchenna N Onyeachom uonyeachom@hvori.org

Locations
Nigeria
National Hospital Abuja Recruiting
Abuja, Federal Capital Territory, Nigeria
State House Medical Center Recruiting
Abuja, Federal Capital Territory, Nigeria
Bwari General Hospital Recruiting
Bwari, Federal Capital Territory, Nigeria
Nigerian Defense Medical Center Recruiting
Abuja, Nigeria
Gwagwalada Specialist Hospital Recruiting
Federal Capital Territory, Nigeria
Sponsors and Collaborators
Healthsystem Plus
Federal Ministry of Health, Nigeria
Akaza Research
Byrne Healthcare
Baim Institute for Clinical Research
Investigators
Principal Investigator: Uchenna N Onyeachom Healthsystem Plus
Principal Investigator: Ngozi A Njepuome Abuja Heart Study
Study Chair: Chimele Abengowe National Hospital, Abuja

Responsible Party: uchenna onyeachom, Study Director/ Principal Investigator, Healthsystem Plus
ClinicalTrials.gov Identifier: NCT00629954     History of Changes
Other Study ID Numbers: HIFA-001
First Posted: March 6, 2008    Key Record Dates
Last Update Posted: September 26, 2013
Last Verified: August 2012

Keywords provided by uchenna onyeachom, Healthsystem Plus:
ABUJA HEART STUDY NIGERIA
CARDIOVASCULAR DISEASES

Additional relevant MeSH terms:
Cardiovascular Diseases
Hypertension
Vascular Diseases